Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02014337
Title Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Corcept Therapeutics
Indications
Therapies
Age Groups:
Covered Countries USA

Facility Status City State Zip Country Details
ACRC/Arizona Clinical Research Center Inc. Tucson Arizona 85715 United States Details
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612 United States Details
Winship Cancer Institute, Emory University Atlanta Georgia 30308 United States Details
Rita Nanda, MD Chicago Illinois 60637 United States Details
Quest Research Royal Oaks Michigan 48073 United States Details
St. Luke's Cancer Institute Kansas City Missouri 64111 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
Cancer Care Centers of South Texas San Antonio Texas 78217 United States Details
Texas Oncology - Tyler Tyler Texas 75702 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field